Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision/version indicator was updated (from v3.5.2 to v3.5.3). This reflects a minor versioning change rather than an update to the study details.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3; no substantive study details or eligibility criteria appear to be affected.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.1%

- Check84 days agoChange DetectedThe update adds a new site revision label (v3.4.2) and removes the previous funding-status notice and earlier revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check92 days agoChange DetectedThe page now displays a government funding notice about NIH operations and an updated site revision to v3.4.1, with the prior v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.